Real-World Effectiveness and Safety of Neoadjuvant Pembrolizumab plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Single-Center Taiwanese Cohort Study

First Author / 第一作者

Han Fang Cheng

Institution / 單位

1Comprehensive Breast Health Center, Department of Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC

Audio / 音訊檔

Author Group / 作者群

Han-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, Chih-Yi Hsu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Jiun-I. Lai, Chin-Jung Feng, Yen-Jen Chen, Bo-Fang Chen, Jen-Hwey Chiu, Ling-Ming Tseng, Chi-Cheng Huang

Author Group Institution/ 作者群單位

Comprehensive Breast Health Center, Department of Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC. School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan, ROC. Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC. Department of Nurse, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC. Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan, ROC. Division of Plastic and Reconstruction Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC. Institute of Epidemiology and Preventive Medicine, College of Medicine, National Taiwan University, Taipei City, Taiwan, ROC.

Category / 主題分類

Clinical Research

Keyword / 關鍵字

TNBC, immunotherapy, real-world data

Back to list